Ratings Kenvue Inc.

Equities

KVUE

US49177J1025

Market Closed - Nyse Other stock markets 04:00:02 2024-05-07 pm EDT			5-day change	1st Jan Change
20.08 ^USD	+6.36%		+6.70%	-6.73%

May. 07	Health Care Up Amid Mixed Earnings - Health Care Roundup	DJ
May. 07	News Highlights : Top Company News of the Day - Tuesday at 3 PM ET	DJ

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company appears highly valued given the size of its balance sheet.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last few months, analysts have been revising downwards their earnings forecast.
Over the past four months, analysts' average price target has been revised downwards significantly.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.

Ratings chart - Surperformance

Sector: Personal Products

	1st Jan change	Capi.	ESG Refinitiv
KENVUE INC.	-6.73%	38.45B	-
PROCTER & GAMBLE COMPANY	+13.12%	391B	C-
UNILEVER PLC	+10.84%	132B	B-
COLGATE-PALMOLIVE COMPANY	+18.03%	77.19B	A+
HINDUSTAN UNILEVER LIMITED	-12.57%	67B	A-
ESTEE LAUDER	-11.46%	46.43B	B+
BEIERSDORF	+6.19%	34.77B	B-
ESSITY AB	+10.96%	18.02B	A-
GODREJ CONSUMER PRODUCTS LIMITED	+18.64%	16.21B	B
DABUR INDIA LIMITED	+0.17%	11.86B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes